Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

with Janssen, is working with the FDA to determine the implications of this Breakthrough Therapy Designation to the ongoing and planned development and the filing requirements for the use of ibrutinib in patients with mantle cell lymphoma (MCL) and in patients with Waldenstrom's macroglobulinemia (WM). The Company expects to finalize the MCL filing prior to year end and will provide guidance on the WM filing after further discussions with the FDA. Pharmacyclics will provide regulatory updates as further information on implementing the requirements with respect to Breakthrough Therapies are developed by the Secretary of Health and Human Services.

ASH 2012

Pharmacyclics had 9 oral and 9 poster presentations at this year's American Society of Hematology (ASH) Annual Meeting providing an update on the broad development program of ibrutinib.  Among the data presented at ASH were updates on the safety and efficacy of ibrutinib in the most mature clinical programs of chronic lymphocytic leukemia (CLL) and MCL. Two of the CLL oral presentations were acknowledged as 'Best of ASH' during the event. Additionally, investigators presented data in diffuse large b-cell lymphoma (DLBCL), follicular lymphoma (FL), and multiple myeloma (MM).  Most of the oral presentations can be found on the Company's website. 

Phase II/III clinical trials initiated with ibrutinib in the collaboration:

  • Phase III study of ibrutinib versus ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL), RESONATE™. This trial is a randomized, multi-center, open-label Phase III trial of ibrutinib as a monotherapy. The primary endpoint of the study is to demonstrate a clinically significant improvement in progression-free survival when compared to ofatumumab. This global study is open and Pharmacyclics plans to enroll 350 patients worldwide. The Company anticipates having this st
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
    2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    7. Pharmasset Reports Fiscal Year End 2011 Financial Results
    8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
    10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
    11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... NY (PRWEB) July 31, 2014 North Shore ... York City, partnered with GI Energy, one of the nation’s ... a $13 million upgrade of its 43-year-old CHP system. The ... and in an effort to extend the life of the ... generators and associated electrical and heat recovery equipment, while maintaining ...
    (Date:7/31/2014)... , July 31, 2014  Smith & ... global medical technology business, today announced its entry ... the HAT-TRICK™ Lesser Toe Repair System. Comprised of ... products for metatarsophalangeal (MTP) ligament repair and reconstruction, ... implant for proximal Inter-phalanges (PIP) fusion, also known ...
    (Date:7/31/2014)... 31, 2014 Although RNA-Sequencing is ... first transcriptome-wide analyses appearing around 2008, RNA-Sequencing has ... RNA measurement. In the last several years, assays ... work with smaller input amounts, process degraded RNA, ... samples). On the bioinformatics side, there have been ...
    (Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, LLC ( ... cell biotechnologies. Currently the company holds seven recently ... applications currently under examination by the U.S. Patent and ... the most vexing problems in adult stem cell biology ... difficult to identify; and they have been difficult to ...
    Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3
    ... July 28, 2011 As the fight over deficit reform ... Association (NEBA) is urging lawmakers from across the region to ... economy and ensure it doesn,t become a victim of short-sighted ... options for treatment and medications available to seniors, but would ...
    ... (NASDAQ: ITMN ) today announced that it will ... 4, 2011. A live conference call and webcast will be ... day to discuss business highlights and financial results for the ... To access the live teleconference, dial 888-567-5125 (U.S.) or 706-643-9223 ...
    ... INDIANAPOLIS, and WALTHAM, Mass., July 28, 2011 ... Eli Lilly and Company (NYSE: LLY ) and ... the companies have submitted their reply to a complete response ... Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), ...
    Cached Biology Technology:Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy 2InterMune to Release Second Quarter Financial Results on August 4 2BYDUREON™ Reply Submitted to FDA 2BYDUREON™ Reply Submitted to FDA 3BYDUREON™ Reply Submitted to FDA 4BYDUREON™ Reply Submitted to FDA 5BYDUREON™ Reply Submitted to FDA 6BYDUREON™ Reply Submitted to FDA 7
    (Date:7/31/2014)... studies have shown that marine noise can affect animal ... the Universities of Bristol and Exeter and the cole ... demonstrated that boat noise stops embryonic development and increases ... the sea slug Stylocheilus striatus used in ... away and later feed on toxic alga but this ...
    (Date:7/30/2014)... and tended her eggs until they hatched 4.5 years ... in the open-access journal PLOS ONE by ... colleagues. , Octopuses typically have a single reproductive period ... care of their fertilized eggs until they hatch. Shallow-water ... 3 months, but little is known about the brooding ...
    (Date:7/30/2014)... University of Helsinki and the Universitat Autnoma de Barcelona ... changes which have taken millions of years to occur. ... of mice teeth, induced in the laboratory, scientists have ... observed in the fossil registry of rodent species which ... To modify the development of their teeth, the team ...
    Breaking Biology News(10 mins):Boat noise impacts development and survival of sea hares 2Deep-sea octopus has longest-known egg-brooding period 2Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2
    ... Scientists have pinpointed specific mutations that allow a common plant ... the March issue of the Journal of General Virology. ... and hosts could provide insight to how some viruses manage ... better idea of how animal diseases are generated. Researchers ...
    ... February 11, 2010-Academic programs and courses have increased in ... In a recent study published in the 2010 volume ... Sciences Education, researchers from Cornell University and North ... and experiential learning, which are often a part of ...
    ... LIVERMORE, Calif. - Through Laboratory soil cleanup methods, ... nuclear tests were conducted on the atolls and in ... have lower radioactive levels than the average background dose ... The National Nuclear Security Administration,s Lawrence Livermore National Laboratory ...
    Cached Biology News:The genetic secrets to jumping the species barrier 2Hands-on: From classroom to employment 2LLNL research at Marshall Islands could lead to resettlement 2
    ... Varioskan is a high performance spectral ... and incubator. With the advanced SkanIt ... reliability for drug discovery assay development. ... fluorescence intensity, time-resolved fluorescence and photometric ...
    ... RCT series of refrigerated cold traps offers ... of low volatility/aqueous solvents or high volatility ... other vacuum concentrators/centrifugal evaporators. Also used for ... such as used in electron microscopes. Can ...
    96 Well Plate UB, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
    96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
    Biology Products: